title: Longitudinal hysteroscopic follow-up during tamoxifen treatment.
authors.forename: P
authors.initials: P
authors.lastname: Neven
authors.forename: X
authors.initials: X
authors.lastname: De Muylder
authors.forename: Y
authors.initials: Y
authors.lastname: Van Belle
authors.forename: I
authors.initials: I
authors.lastname: Van Hooff
authors.forename: G
authors.initials: G
authors.lastname: Vanderick
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D015331:Cohort Studies; D004714:Endometrial Hyperplasia / Q000139:chemically induced / Q000453:epidemiology; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015907:Hysteroscopy; D017698:Postmenopause; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen